Expression and significance of miR-21 in multiple myeloma patients.

@article{Wang2016ExpressionAS,
  title={Expression and significance of miR-21 in multiple myeloma patients.},
  author={J H Wang and W W Zhou and B. X. Liu and Dongliang Man and Z. -D. Yang and F R Liu and Hong Shang},
  journal={Genetics and molecular research : GMR},
  year={2016},
  volume={15 1}
}
The aim of the present study is to examine the expression level of peripheral mir-21 in multiple myeloma (MM) patients and to determine its clinical significance. MM patients (30), monoclonal gammopathy of undetermined significance (MGUS) patients (14), and normal controls (20) were recruited to determine the serum level of β2-MG, IgA and IgM, IgG, λ, κ, TP, ALB, Hb, LDH, and Ca(2+). Gene expression of mir-21 was quantified by SYBR green real-time fluorescent quantitative PCR. We found that the… 

Figures and Tables from this paper

The Impact of Serum MicroRNA-21 on Outcome of Diffuse Large B-Cell Lymphoma Patients

Serum miRNA-21 may be employed as valuable non-invasive prognostic marker in DLBCL patients treated with R-CHOP regimen and overall survival was significantly worse in patients with high miRNA21 expression levels compared to those with low expression levels.

Gambogenic Acid Exerts Antitumor Activity in Hypoxic Multiple Myeloma Cells by Regulation of miR-21

It is found that GNA exhibits remarkable apoptotic activity against MM cells even under hypoxia, and in vivo study revealed that intravenous GNA injection could significantly suppress tumor growth and the miR-21/PTEN pathway is involved in GNA's anti-tumor effects.

Profiling of circulating exosomal miRNAs in patients with Waldenström Macroglobulinemia

It is shown that circulating exosomes and their miRNA content represent unique markers of the tumor and its microenvironment and suggest that environmental and clonal changes occur in patients at early stages of disease progression before symptoms occur.

MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease

The role and significance of microRNAs (miRNAs) as potential diagnostic biomarkers to predict the clinical transition from MGUS/SMM status to MM are discussed, highlighting their key role as novel players within the field of MM and related premalignant conditions.

Identification of MicroRNAs With In Vivo Efficacy in Multiple Myeloma-related Xenograft Models

This work searched the literature for microRNAs, which increase or inhibit in vivo efficacy in multiple-myeloma-related xenograft models, and identified six up-regulated and twelve down-regulated miRs, which deserve further preclinical validation.

Molecular Mechanisms of Bortezomib Action: Novel Evidence for the miRNA–mRNA Interaction Involvement

Examination of changes in global gene and miRNA expression and analyzed the identified miRNA–mRNA interactions after bortezomib exposure in human neuroblastoma cells to define pathways affected by this agent in this type of cells found that 719 genes and 28 miRNAs were downregulated, and 319 genes and 61 mi RNAs were upregulated in neuroblast cancer cells treated with bortzomib.

Targeting microRNA in hematologic malignancies.

This review provides a comprehensive overview of the role of miRNAs for diagnosis, prognosis, and therapeutic potential in hematologic malignancies and targets miRNA biogenesis or pathways targeting.

References

SHOWING 1-10 OF 16 REFERENCES

MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis

A MM miRNA signature is described, which includes miRNAs that modulate the expression of proteins critical to myeloma pathogenesis that were shown to down regulate expression of SOCS-1 and miR-19a and 19b.

Identification of novel miR-21 target proteins in multiple myeloma cells by quantitative proteomics.

It is demonstrated that miR-21 enhances the STAT3-dependent signal pathway by inhibiting the function ofPIAS3 and that down-regulation of PIAS3 contributes to the oncogenic function of miR -21.

Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.

A novel RT-qPCR-DS can improve the efficiency of miR assessment and use of this assay to detect circulating miR-21 has diagnostic and prognostic potential in breast cancer.

Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma

This is the first description of circulating microRNAs and suggests that micro RNAs have potential as non‐invasive diagnostic markers for DLBCL and possibly other cancers.

Study of specific genetic and epigenetic variables in multiple myeloma

The identification of Snk/Plk2 as a novel methylated gene in MM is reported and it is shown that methylation is not influenced in this CpG island or in that of a previously describedethylated gene, CDKN2A, in MM.

Set9, NF-κB, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells

In U266 cells, berberine suppresses NF-κB nuclear translocation via Set9-mediated lysine methylation, leads to decrease in the levels miR21 and Bcl-2, which induces ROS generation and apoptosis.

Circulating MicroRNAs, miR‐21, miR‐122, and miR‐223, in patients with hepatocellular carcinoma or chronic hepatitis

Serum miRNAs presented in serum of patients with HCC and chronic hepatitis have strong potential to serve as novel biomarkers for liver injury but not specifically for HCC, according to Receiver‐operator characteristic (ROC) curve analyses.

Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation

Investigation of microRNA-21 (miR-21) expression changes in myeloma cells that adhered to bone marrow stromal cells found that up-regulation of miR- 21 expression was partially driven by nuclear factor-κB (NF-κBs) signaling via myel cancer cell adhesion to BMSCs.

MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma.

Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer.

It is demonstrated that the gene encoding oncogenic microRNA-21 (miR-21) is controlled by an upstream enhancer containing 2 Stat3 binding sites strictly conserved since the first observed evolutionary appearance of miR- 21 and Stat3.